Wave Life Sciences, Inc.
WVE- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001631574
In the last 90 days, Wave Life Sciences, Inc. insiders filed 0 open-market purchases and 4 sales; 239 institutions reported holding it in 13F filings for Q2 2026, worth $1.06B in total; superinvestors Maverick Capital and Duquesne Family Office hold it.
Q1 2025 vs. Q4 2024
How the institutions holding Wave Life Sciences, Inc. changed between Q4 2024 and Q1 2025.
All holders in Q1 2025All holders in Q4 2024
| Measure | Q4 2024 | Of which not filed for Q1 2025 | Q1 2025 | Change |
|---|---|---|---|---|
| Holders | 184 | 1 | 197 | +14 |
| Shares | 128.6M | 553.4K | 131.4M | +3.33M (+2.6%) |
| Value | $1.59B | $6.85M | $1.06B | −$522.2M (−33.0%) |
1 institution that held it in Q4 2024 haven't filed for Q1 2025 yet. Not filing isn't selling, so the changes leave them out.
New holders (34)
Institutions that held Wave Life Sciences, Inc. at the end of Q1 2025 but not at the end of Q4 2024.
Sold out (20)
Institutions that held Wave Life Sciences, Inc. at the end of Q4 2024 and filed for Q1 2025 without it.
| Institution | Shares, Q4 2024 | Value, Q4 2024 |
|---|---|---|
| Cinctive Capital Management LP | 191,963 | $2.37M |
| Marshall Wace, LLP | 183,875 | $2.27M |
| Crestline Management, LP | 158,336 | $1.96M |
| Bamco Inc | 85,000 | $1.05M |
| Quantbot Technologies LP | 68,927 | $852.6K |
| SG Americas Securities, LLC | 53,419 | $661.0K |
| Handelsbanken Fonder AB | 50,800 | $628.0K |
| Algert Global LLC | 42,564 | $526.5K |
| UBS Oconnor LLC | 39,767 | $491.9K |
| Los Angeles Capital Management LLC | 24,461 | $302.6K |
| Virtu Financial LLC | 20,819 | $258.0K |
| Wolverine Trading, LLC | 19,970 | $247.8K |
| Occudo Quantitative Strategies LP | 19,936 | $246.6K |
| Corton Capital Inc. | 17,051 | $210.9K |
| Westwood Wealth Management | 10,000 | $123.7K |
| Virtus ETF Advisers LLC | 5,133 | $63.5K |
| Quarry LP | 5,000 | $61.9K |
| Aster Capital Management (DIFC) Ltd | 858 | $10.6K |
| Skopos Labs, Inc. | 293 | $3.63K |
| Lazard Asset Management LLC | 217 | $2.00K |
Not filed for Q1 2025 yet (1)
Institutions that held Wave Life Sciences, Inc. at the end of Q4 2024 and haven't filed a 13F for Q1 2025. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q4 2024 | Value, Q4 2024 |
|---|---|---|
| Nuveen Asset Management, LLC | 553,439 | $6.85M |